News

Filter

Current filters:

OncologyMedicine

1 to 9 of 15 results

ValiRx to collaborate with Deutsches Krebsforschungzentrum on further development of GeneICE

ValiRx to collaborate with Deutsches Krebsforschungzentrum on further development of GeneICE

13-11-2014

Cancer diagnostics and personalized medicines specialist ValiRx has agreed to collaborate with Deutsches…

BiologyBiotechnologyGermanyMedicineMolecular geneticsOncologyResearchValiRx

European Commission approves Gilead’s Zydelig for blood cancer

European Commission approves Gilead’s Zydelig for blood cancer

19-09-2014

The European Commission has granted marketing authorization for US biotech major Gilead Sciences’ Zydelig…

BiotechnologyEuropeGilead SciencesLymphomaMedicineOncologyRegulationZydelig

Oncothyreon acquires Alpine Biosciences

Oncothyreon acquires Alpine Biosciences

12-08-2014

US biotech firm Oncothyreon says that it has acquired Alpine Biosciences, of Seattle, Washington, a privately…

Alpine BiosciencesBiotechnologyBusiness FinanceImmunotherapyMedicineMergers & AcquisitionsOncologyOncothyreonRare diseasesUSA

Ono and Meiji Seika make development and commercialization agreement on Limaprost

Ono and Meiji Seika make development and commercialization agreement on Limaprost

29-07-2014

Japanese companies Ono Pharmaceutical and Meiji Seika have announced an agreement on the development…

IndonesiaJapanLicensinglimaprostMedicineMeiji Seika PharmaOncologyOno PharmaceuticalPharmaceuticalSpinal stenosisThailand

$25 million milestone for Incyte on Japanese approval of Jakavi

$25 million milestone for Incyte on Japanese approval of Jakavi

08-07-2014

US biopharma company Incyte says it has earned a $25 million milestone payment from Swiss drug major…

BiotechnologyBusiness FinanceBusiness FinanceFinancialIncyteJakaviJapanMajorMedicineNovartisOncologyRegulationRuxolitinib

US FDA approves Eisai’s Aloxi for children and extends exclusivity

US FDA approves Eisai’s Aloxi for children and extends exclusivity

29-05-2014

Japanese drug major Eisai announced today that the antiemetic agent Aloxi (palonosetron HCI) has been…

AloxiAntiemeticsEisaiHealth Medical PharmaJapanMedicineOncologyPharmaceuticalRegulationUnited StatesUSAVomiting

1 to 9 of 15 results

Back to top